ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 95 filers reported holding ALLOVIR INC in Q2 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $660,336 | -39.8% | 307,133 | -4.8% | 0.00% | – |
| Q2 2023 | $1,097,272 | +72.4% | 322,727 | +99.8% | 0.00% | – |
| Q1 2023 | $636,464 | -42.6% | 161,539 | -25.3% | 0.00% | – |
| Q4 2022 | $1,108,742 | -18.9% | 216,129 | +24.7% | 0.00% | – |
| Q3 2022 | $1,367,000 | +53.3% | 173,331 | -24.2% | 0.00% | – |
| Q2 2022 | $892,000 | +22.2% | 228,667 | +111.5% | 0.00% | – |
| Q1 2022 | $730,000 | -39.1% | 108,104 | +16.7% | 0.00% | – |
| Q4 2021 | $1,199,000 | -53.8% | 92,609 | -10.6% | 0.00% | -100.0% |
| Q3 2021 | $2,597,000 | +66.9% | 103,643 | +31.5% | 0.00% | – |
| Q2 2021 | $1,556,000 | -76.3% | 78,841 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $6,559,000 | +463.5% | 280,310 | +826.0% | 0.00% | – |
| Q4 2020 | $1,164,000 | -32.2% | 30,271 | -51.5% | 0.00% | – |
| Q3 2020 | $1,716,000 | – | 62,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $89,310,000 | 1.92% |
| Redmile Group, LLC | 2,325,595 | $89,396,000 | 1.08% |
| Woodline Partners LP | 1,039,880 | $39,973,000 | 1.06% |
| EcoR1 Capital, LLC | 447,012 | $17,183,000 | 0.92% |
| Samsara BioCapital, LLC | 82,336 | $3,165,000 | 0.32% |
| CNA FINANCIAL CORP | 11,285 | $434,000 | 0.14% |
| AMERICAN INTERNATIONAL GROUP, INC. | 910,419 | $34,997,000 | 0.13% |
| Virtus ETF Advisers LLC | 7,339 | $282,000 | 0.12% |
| Maven Securities LTD | 19,901 | $799,000 | 0.08% |
| TCW GROUP INC | 216,135 | $8,308,000 | 0.07% |